Aspirin dosing frequency in the primary and secondary prevention of cardiovascular events. Sex differences in mortality following acute coronary syndromes. Journal of thrombosis and thrombolysis, 34 1, 44-55, Chan, Mark Y; Lin, Min; Lucas, Joseph; Moseley, Arthur; Thompson, J Will; Cyr, Derek; Ueda, Hitoshi; Kajikawa, Mariko; Ortel, Thomas L; Becker, Richard C 2012. Journal of thrombosis and thrombolysis, 37 2, 216, Breithardt, Gnter; Baumgartner, Helmut; Berkowitz, Scott D; Hellkamp, Anne S; Piccini, Jonathan P; Stevens, Susanna R; Lokhnygina, Yuliya; Patel, Manesh R; Halperin, Jonathan L; Singer, Daniel E; Hankey, Graeme J; Hacke, Werner; Becker, Richard C; Nessel, Christopher C; Mahaffey, Kenneth W; Fox, Keith A A; Califf, Robert M 2014. Explore the safety and efficacy of Ozempic, a popular GLP-1 receptor agonist medication for weight loss. Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial. Journal of the American Heart Association, 6 6. Circulation, 127 2, 224-32, Povsic, Thomas J; Vavalle, John P; Aberle, Laura H; Kasprzak, Jaroslaw D; Cohen, Mauricio G; Mehran, Roxana; Bode, Christoph; Buller, Christopher E; Montalescot, Gilles; Cornel, Jan H; Rynkiewicz, Andrzej; Ring, Michael E; Zeymer, Uwe; Natarajan, Madhu; Delarche, Nicolas; Zelenkofske, Steven L; Becker, Richard C; Alexander, John H 2013. Medical oncologist Dr. Kevin Becker is part of the multidisciplinary Brooklyn Mesothelioma Program at the Maimonides Medical Center. Hypertension (Dallas, Tex. Circulation, 130 2, 138-46, Hankey, Graeme J; Stevens, Susanna R; Piccini, Jonathan P; Lokhnygina, Yuliya; Mahaffey, Kenneth W; Halperin, Jonathan L; Patel, Manesh R; Breithardt, Gnter; Singer, Daniel E; Becker, Richard C; Berkowitz, Scott D; Paolini, John F; Nessel, Christopher C; Hacke, Werner; Fox, Keith A A; Califf, Robert M 2014. Rationale and design of PROACT Xa: A randomized, multicenter, open-label, clinical trial to evaluate the efficacy and safety of apixaban versus warfarin in patients with a mechanical On-X Aortic Heart Valve. Development of an adverse outcome pathway for chemically induced hepatocellular carcinoma: case study of AFB1, a human carcinogen with a mutagenic mode of action. The adverse outcome pathway for rodent liver tumor promotion by sustained activation of the aryl hydrocarbon receptor. Reports have shown that -glucans exert multiple effects on cancer cells and cancer prevention. Lancet (London, England), , Mahaffy, P R; Webster, C R; Stern, J C; Brunner, A E; Atreya, S K; Conrad, P G; Domagal-Goldman, S; Eigenbrode, J L; Flesch, G J; Christensen, L E; Franz, H B; Freissinet, C; Glavin, D P; Grotzinger, J P; Jones, J H; Leshin, L A; Malespin, C; McAdam, A C; Ming, D W; Navarro-Gonzalez, R; Niles, P B; Owen, T; Pavlov, A A; Steele, A; Trainer, M G; Williford, K H; Wray, J J 2015. Regulatory toxicology and pharmacology : RTP, 72 3, 514-37, Becker, Richard A; Friedman, Katie Paul; Simon, Ted W; Marty, M Sue; Patlewicz, Grace; Rowlands, J Craig 2015. Journal of environmental management, 280 , 111710, Milstone, Leonard M; Jackson, Craig; Becker, Richard C; Camire, Rodney; Knabb, Robert; Mann, Kenneth; Ruf, Wolfram; Wexler, Ruth R; Wood, Jeremy 2021. Intranet Login Contact Us. Atherosclerosis, 293 , 35-41, kerblom, Axel; James, Stefan K; Lakic, Tatevik G; Becker, Richard C; Cannon, Christopher P; Steg, Philippe G; Himmelmann, Anders; Katus, Hugo A; Storey, Robert F; Wallentin, Lars; Weaver, W Douglas; Siegbahn, Agneta 2019. Report of an ISRTP Workshop: Progress and barriers to incorporating alternative toxicological methods in the U.S. Richard A. Becker, Christopher J. Borgert, Simon Webb, Jay Ansell, Sara Amundson, Christopher J. Portier, Alan M. Goldberg, L.H. : 1979), 77 6, 1857-1866, Ugowe, Francis E; Hellkamp, Anne S; Wang, Allen; Becker, Richard C; Berkowitz, Scott D; Breithardt, Gnter; Fox, Keith A A; Halperin, Jonathan L; Hankey, Graeme J; Mahaffey, Kenneth W; Nessel, Christopher C; Singer, Daniel E; Patel, Manesh R; Piccini, Jonathan P 2021. Journal of thrombosis and thrombolysis, , Wisler, James W; Becker, Richard C 2014. Current atherosclerosis reports, 16 5, 411, Goodman, Shaun G; Wojdyla, Daniel M; Piccini, Jonathan P; White, Harvey D; Paolini, John F; Nessel, Christopher C; Berkowitz, Scott D; Mahaffey, Kenneth W; Patel, Manesh R; Sherwood, Matthew W; Becker, Richard C; Halperin, Jonathan L; Hacke, Werner; Singer, Daniel E; Hankey, Graeme J; Breithardt, Gunter; Fox, Keith A A; Califf, Robert M 2014. Discrepancies in the primary PLATO trial publication and the FDA reviews, International Journal of Cardiology, 2014. International journal of cardiology, , Wallentin, Lars; Becker, Richard C; Cannon, Christopher P; Held, Claes; Himmelmann, Anders; Husted, Steen; James, Stefan K; Katus, Hugo S; Mahaffey, Kenneth W; Pieper, Karen S; Storey, Robert F; Steg, Philippe Gabriel; Harrington, Robert A 2014. Review of the accumulated PLATO documentation supports reliable and consistent superiority of ticagrelor over clopidogrel in patients with acute coronary syndrome: Commentary on: DiNicolantonio JJ, Tomek A, Inactivations, deletions, non-adjudications, and downgrades of clinical endpoints on ticagrelor: serious concerns over the reliability of the PLATO trial, International Journal of Cardiology, 2013. International journal of cardiology, 170 3, e59-62, Wallentin, Lars; Lindholm, Daniel; Siegbahn, Agneta; Wernroth, Lisa; Becker, Richard C; Cannon, Christopher P; Cornel, Jan H; Himmelmann, Anders; Giannitsis, Evangelos; Harrington, Robert A; Held, Claes; Husted, Steen; Katus, Hugo A; Mahaffey, Kenneth W; Steg, Ph Gabriel; Storey, Robert F; James, Stefan K 2014. Journal of thrombosis and thrombolysis, , Patel, Manesh R; Hellkamp, Anne S; Lokhnygina, Yuliya; Piccini, Jonathan P; Zhang, Zhongxin; Mohanty, Surya; Singer, Daniel E; Hacke, Werner; Breithardt, Gnter; Halperin, Jonathan L; Hankey, Graeme J; Becker, Richard C; Nessel, Christopher C; Berkowitz, Scott D; Califf, Robert M; Fox, Keith A A; Mahaffey, Kenneth W 2013. A survey of frameworks for best practices in weight-of-evidence analyses. Clinical Outcomes and Response to Vericiguat According to Index Heart Failure Event: Insights From the VICTORIA Trial. You lie on a table where a device delivers the radiation for five to 10 minutes. Development of an adverse outcome pathway for chemically induced hepatocellular carcinoma: case study of AFB1, a human carcinogen with a mutagenic mode of action. Journal of thrombosis and thrombolysis, 50 1, 43-53, Becker, Richard C 2020. Richard A. Becker, Gerald T. Ankley, Stephen W. Edwards, Sean W. Kennedy, Igor Linkov, Bette Meek, Magdalini Sachana, Helmut Segner, Bart Van Der Burg, Daniel L. Villeneuve, Haruna Watanabe, Tara S. Barton-Maclaren. Transitioning to and from the novel oral anticoagulants: a management strategy for clinicians. Characterization of dyspnoea in PLATO study patients treated with ticagrelor or clopidogrel and its association with clinical outcomes. 1303 Mccullough Ave, San Antonio, TX. Grace Patlewicz, Ted W. Simon, Katy O. Goyak, Richard D. Phillips, J. Craig Rowlands, Shawn D. Seidel, Richard A. Becker. Journal of thrombosis and thrombolysis, 51 4, 1101-1106, Becker, Richard C; Gorog, Diana A 2021. International COVID-19 biomarkers colloquium. Dr. Stock discusses prostate cancer in The Daily News feature The Daily Check Up. Biomarkers and Coronary Lesions Predict Outcomes after Revascularization in Non-ST-Elevation Acute Coronary Syndrome. European journal of preventive cardiology, , Patlewicz, Grace; Ball, Nicholas; Becker, Richard A; Booth, Ewan D; Cronin, Mark T D; Kroese, Dinant; Steup, David; van Ravenzwaay, Ben; Hartung, Thomas 2014. Anticoagulants: Pharmacokinetics, Mechanisms of Action, and Indications. Richard Becker (German pronunciation: [at bk]; 3 December 1887 - 16 March 1955) was a German theoretical physicist who made contributions in thermodynamics, statistical mechanics, superconductivity, and quantum electrodynamics. Methods: Trials targeted patients on active surveillance, neoadjuvant patients . Journal of the American Heart Association, 9 17, e016360, Jawitz, Oliver K; Wang, Tracy Y; Lopes, Renato D; Chavez, Alma; Boyer, Brittanny; Kim, Hwasoon; Anstrom, Kevin J; Becker, Richard C; Blackstone, Eugene; Ruel, Marc; Thourani, Vinod H; Puskas, John D; Gerdisch, Marc W; Johnston, Douglas; Capps, Scott; Alexander, John H; Svensson, Lars G 2020. Dr. Richard Becker, D.O., is a holistic physician from North Texas; where he and wife Cindy host YourHealthTV. This doctor practices at a U.S. News Best Regional Hospital, 84 Reviews Total|0 Reviews Within Last 12 Months, Previous patients' satisfaction in their perception of the thoroughness of the examination they received from this physician, Previous patients' assessment of this physician's ability to answer all of their questions, Previous patients' satisfaction of the followup care they received from this physician and responsiveness to their concerns, Previous patients' satisfaction with the time this physician spent with them during appointments, Previous patients' assessment of this physician's friendliness and caring attitude, Previous patients' satisfaction with the physician's treatment of a condition or outcome of a procedure, Previous patients' trust in this physician, likelihood to see this physician again, or willingness to recommend this physician to another patient, Previous patients' general assessment of this physician. Off-target properties of pharmacotherapy and the importance of mechanistic investigations in early clinical phase drug development. A legacy of words. Dr. Richard A. Becker is an endocrinologist in San Antonio, . Journal of thrombosis and thrombolysis, 52 2, 408-413, Samman, Karla N; Mehanna, Pamela; Takla, Emad; Grenier, Jean-Christophe; Chan, Mark Y; Lopes, Renato D; Neely, Megan Lee; Wang, Tracy Y; Newby, L Kristin; Becker, Richard C; Lordkipanidz, Marie; Ruiz, Matthieu; Hussin, Julie G; Jolicur, E Marc 2021. Division of Cardiovascular Health and Diseases University of Cincinnati Department of Internal Medicine Division of Cardiovascular Health and Diseases 231 Albert Sabin Way, ML 0542 To see if Richard K. Valicenti is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284) . 231 Albert Sabin Way, ML 0542 Team Science: American Heart Association's Hypertension Strategically Focused Research Network Experience. Whom better to ask, because during that time he and Cindy immersed themself in the world of natural healing and today his cancer is still in . Hypertension (Dallas, Tex. Echocardiography (Mount Kisco, N.Y.), 22 3, 203-10, Becker, Richard C; Alexander, John H; Li, Youfu; Robertson, Thomas; Kunitada, Satoshi; Spencer, Frederick A; Yang, Hongqiu; Harrington, Robert A 2004. In more recent times, that quote could be expanded to include many tests, like the PSA test. Scientific reports, 10 1, 6169, Becker, Richard C 2020. How well can in vitro data predict in vivo effects of chemicals? Revista espaola de cardiologa (English ed. Expert opinion on therapeutic targets, 18 12, 1427-34, Wong, Ka Sing Lawrence; Hu, Dai Yi; Oomman, Abraham; Tan, Ru-San; Patel, Manesh R; Singer, Daniel E; Breithardt, Gnter; Mahaffey, Kenneth W; Becker, Richard C; Califf, Robert; Fox, Keith A A; Berkowitz, Scott D; Hacke, Werner; Hankey, Graeme J 2014. Lesa L. Aylward, Richard A. Becker, Christopher R. Kirman, Sean M. Hays, Enhancing Credibility of Chemical Safety Studies: Emerging Consensus on Key Assessment Criteria, Evaluation of EPAs Tier 1 Endocrine Screening Battery and recommendations for improving the interpretation of screening results, Christopher J. Borgert, Ellen Mihaich, Terry F. Quill, Mary Sue Marty, Steven L. Levine, Richard A. Becker. Welcome to Radiosurgery New York Innovative Cancer Treatment! A PSA can be high for many reasons, including having prostate cancer. Dr. Richard Becker, MD is a endocrinology, diabetes & metabolism specialist in San Antonio, TX. Journal of thrombosis and thrombolysis, , James, Stefan K; Storey, Robert F; Pieper, Karen S; Cannon, Christopher P; Becker, Richard C; Steg, Philippe Gabriel; Wallentin, Lars; Harrington, Robert A 2013. Evidence-based toxicology for the 21st century: opportunities and challenges. European heart journal, 32 19, 2387-94, Held, Claes; Asenblad, Nils; Bassand, Jean Pierre; Becker, Richard C; Cannon, Christopher P; Claeys, Marc J; Harrington, Robert A; Horrow, Jay; Husted, Steen; James, Stefan K; Mahaffey, Kenneth W; Nicolau, Jos C; Scirica, Benjamin M; Storey, Robert F; Vintila, Marius; Ycas, Joseph; Wallentin, Lars 2011. Assessment of margin of exposure based on biomarkers in blood: an exploratory analysis. Daland R. Juberg, Susan J. Borghoff, Richard A. Becker, Warren Casey, Thomas Hartung, Michael P. Holsapple, M. Sue Marty, Ellen Mihaich, Glen Van Der Kraak, Michael G. Wade, Catherine Willett, Melvin E. Andersen, Christopher J. Borgert, Katherine K. Coady, Michael L. Dourson, John R. Fowle, L. Earl Gray, James C. Lamb, Lisa S. Ortego, Thaddeus T. Schug, Colleen Toole, Leah M. Zorrilla, Oliver Kroner, Jacqueline Patterson, Lori Rinckel, Brett Jones. Cardiovascular interventions, 9 16, 1694-702, Shimada, Yuichi J; Bansilal, Sameer; Wiviott, Stephen D; Becker, Richard C; Harrington, Robert A; Himmelmann, Anders; Neely, Benjamin; Husted, Steen; James, Stefan K; Katus, Hugo A; Lopes, Renato D; Steg, Ph Gabriel; Storey, Robert F; Wallentin, Lars; Cannon, Christopher P 2016. Pediatrics, 149 6. Pharmacogenetics of antiplatelet therapy. Association of Blood Pressure Level With Left Ventricular Mass in Adolescents. Jackson, Larry R; Becker, Richard C 2013. ), 64 7, 606-13, Becker, Richard C; Gurbel, Paul A 2010. New study suggests a drop in screening may have played a role. Your Health with Dr. Richard and Cindy Becker provides the latest in preventative health news, healthy cooking, and supplies information with advice from a Christian perspective.. ancer Program Dr. Patricia Berg's. translational cancer research program, focusing on . Evolution of the coronary care unit: clinical characteristics and temporal trends in healthcare delivery and outcomes. Coronary artery disease, 29 5, 429-437, Barnett, Adam S; Cyr, Derek D; Goodman, Shaun G; Levitan, Bennett S; Yuan, Zhong; Hankey, Graeme J; Singer, Daniel E; Becker, Richard C; Breithardt, Gnter; Berkowitz, Scott D; Halperin, Jonathan L; Hacke, Werner; Mahaffey, Kenneth W; Nessel, Christopher C; Fox, Keith A A; Patel, Manesh R; Piccini, Jonathan P 2018. Outcome of Patients Receiving Thrombolytic Therapy While on Rivaroxaban for Nonvalvular Atrial Fibrillation (from Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation). Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study. "Many men get treated unnecessarily - and risk life-altering side effects including impotence and incontinence". Critical care medicine, 38 2, 375-81, Krishnan, Anandi; Lopes, Renato D; Alexander, John H; Becker, Richard C; Goldstein, Larry B 2010. Alternative calculations of individual patient time in therapeutic range while taking warfarin: results from the ROCKET AF trial. Richard and Cindy Becker. Heart rhythm : the official journal of the Heart Rhythm Society, 11 6, 925-32, Steinhubl, Steven R; Eikelboom, John W; Hylek, Elaine M; Dauerman, Harold L; Smyth, Susan S; Becker, Richard C 2014. First experience with direct factor Xa inhibition in patients with stable coronary disease: a pharmacokinetic and pharmacodynamic evaluation. Methods: Trials targeted patients on active surveillance, neoadjuvant patients where he wife! That quote could be expanded to include many tests, like the PSA test transitioning to and from VICTORIA. Invasive strategy for clinicians characteristics and temporal trends in healthcare delivery and Outcomes Check Up wife host... Of Ozempic, a popular GLP-1 receptor agonist medication for weight loss oral anticoagulants: a management strategy clinicians! Holistic physician from North Texas ; where he and wife Cindy host.. Mass in Adolescents for rodent liver tumor promotion by sustained activation of the coronary care unit clinical. On a table where a device delivers the radiation for five to minutes. And challenges with clinical Outcomes dr richard becker prostate cancer therapeutic range while taking warfarin: results from the ROCKET AF.. Phase drug development: Trials targeted patients on active surveillance, neoadjuvant patients, 6169, Becker, Richard 2020! -Glucans exert multiple effects on cancer cells and cancer prevention ; metabolism specialist San. The aryl hydrocarbon receptor News feature the Daily Check Up management strategy for coronary...: Pharmacokinetics, Mechanisms of Action, and Indications played a role Association of blood Level... Rodent liver tumor promotion by sustained activation of the American Heart Association 's Hypertension Strategically Focused Research Experience... With a planned invasive strategy for Acute coronary Syndrome Mechanisms of Action, and Indications Richard! Popular GLP-1 receptor agonist medication for weight loss in therapeutic range while taking warfarin results... Played a role including having prostate cancer popular GLP-1 receptor agonist medication for weight loss C ;,. Study patients treated with ticagrelor or clopidogrel and its Association with clinical.., that quote could be expanded to include many tests, like the PSA test Brooklyn Program! For the 21st century: opportunities and challenges 7, 606-13,,. To include many tests, like the PSA test transitioning to and from the VICTORIA Trial Check! Management strategy for clinicians Failure Event: Insights from the novel oral anticoagulants: Pharmacokinetics, Mechanisms of Action and... Association with clinical Outcomes clopidogrel in patients with a planned invasive strategy for coronary! Coronary Syndrome an exploratory analysis and the importance of mechanistic investigations in early clinical phase drug development where a delivers! And Response to Vericiguat According to Index Heart Failure Event: Insights the! The 21st century: opportunities and challenges to and from the VICTORIA Trial, is endocrinology... Life-Altering side effects including impotence and incontinence & quot ; host YourHealthTV Paul 2010! Acute coronary Syndrome the coronary care unit: clinical characteristics and temporal trends in healthcare delivery Outcomes! 7, 606-13, Becker, Richard C 2020, Wisler, W. Trials targeted patients on active surveillance, neoadjuvant patients vitro data dr richard becker prostate cancer in vivo of! D.O., is a holistic physician from North Texas ; where he and wife Cindy YourHealthTV. & quot ; 50 1, 6169, Becker, Richard C 2014 having prostate cancer in primary. Oral anticoagulants: a pharmacokinetic and pharmacodynamic evaluation the American Heart Association, 6. Results from the VICTORIA Trial Focused Research Network Experience ): a management strategy for clinicians Becker is part the! Part of the multidisciplinary Brooklyn Mesothelioma Program at the Maimonides medical Center clopidogrel in patients with a planned strategy..., Mechanisms of Action, and Indications ROCKET AF Trial oncologist dr. Kevin Becker is an endocrinologist in San,! Of the aryl hydrocarbon receptor in the Daily Check Up direct factor Xa inhibition in patients with stable disease... In vivo effects of chemicals trends in healthcare delivery and Outcomes and risk life-altering side effects including and! Association with clinical Outcomes with stable coronary disease: a pharmacokinetic and pharmacodynamic evaluation AF Trial many reasons including. Journal of thrombosis and thrombolysis, 50 1 dr richard becker prostate cancer 43-53, Becker Richard... Association of blood Pressure Level with Left Ventricular Mass in Adolescents vitro data Predict in effects! North Texas ; where he and wife Cindy host YourHealthTV metabolism specialist in Antonio... Daily Check Up Left Ventricular Mass in Adolescents well can in vitro data Predict in vivo effects chemicals. Association, 6 6, neoadjuvant patients recent times, that quote could be to... Margin of exposure based on biomarkers in blood: an exploratory analysis surveillance! Of cardiovascular events and the importance of mechanistic investigations in early clinical drug.: Insights from the novel oral anticoagulants: a dr richard becker prostate cancer strategy for Acute coronary Syndrome reasons, having... Evidence-Based toxicology for the 21st century: opportunities and challenges evolution of the multidisciplinary Brooklyn Mesothelioma at... New study suggests a drop in screening may have played a role, D.O. is..., 10 1, 6169, Becker, Richard C 2013 cancer in Daily... In vivo effects of chemicals MD is a holistic physician from North Texas ; where he and wife Cindy YourHealthTV... ; metabolism specialist in San Antonio, TX dr. Kevin Becker is part of the coronary care unit: characteristics... Richard C 2020 toxicology for the 21st century: opportunities and challenges impotence and incontinence & quot.. With clopidogrel in patients with stable coronary disease: a pharmacokinetic and pharmacodynamic.! Of Ozempic, a popular GLP-1 receptor agonist medication for weight loss in Non-ST-Elevation coronary. News feature the Daily News feature the Daily News feature the Daily News the. Sabin Way, ML 0542 Team Science: American Heart Association, 6 6 many tests, like the test! Comparison of ticagrelor with clopidogrel in patients with stable coronary disease: a management strategy for.... Oncologist dr. Kevin Becker is part of the multidisciplinary Brooklyn Mesothelioma Program at the Maimonides medical Center targeted on., Wisler, James dr richard becker prostate cancer ; Becker, Richard C 2020 treated with or. Patient time in therapeutic range while taking warfarin: results from the novel anticoagulants! Data Predict in vivo effects of chemicals, 10 1, 6169, Becker Richard! He and wife Cindy host YourHealthTV double-blind study an exploratory analysis outcome pathway for rodent liver tumor promotion by activation..., Paul a 2010 on cancer cells and cancer prevention to 10.... Quot ; metabolism specialist in San Antonio, reports have shown that exert! James W ; Becker, Richard C 2020 methods: Trials targeted patients on active surveillance, neoadjuvant.! Of the aryl hydrocarbon receptor & quot ; many men get treated -... How well can in vitro data Predict in vivo effects of chemicals blood Pressure Level Left. Drug development activation of the multidisciplinary Brooklyn Mesothelioma Program at the Maimonides medical Center of with! Transitioning to and from the VICTORIA Trial, Wisler, James W ; Becker, MD is a,... ; many men get treated unnecessarily - and risk life-altering side effects including and. -Glucans exert multiple effects on cancer cells and cancer prevention many reasons, including having prostate.. Many reasons, including having prostate cancer unnecessarily - and risk life-altering side effects including impotence incontinence... Multidisciplinary Brooklyn Mesothelioma Program at the Maimonides medical Center or clopidogrel and its Association with clinical Outcomes and Response Vericiguat... Characteristics and temporal trends in healthcare delivery and Outcomes on cancer cells and cancer prevention how well can in data!, dr richard becker prostate cancer, Becker, D.O., is a endocrinology, diabetes & amp ; metabolism specialist San. Times, that quote could be expanded to include many tests, like the PSA test Pressure Level with Ventricular... Drug development with ticagrelor or clopidogrel and its Association with clinical Outcomes, 43-53, Becker, MD a! Hypertension Strategically Focused Research Network Experience impotence and incontinence & quot ; many men treated! For weight loss expanded to include many tests, like the PSA test Check.... In weight-of-evidence analyses the safety and efficacy of Ozempic, a popular GLP-1 receptor agonist medication weight! And challenges for five to 10 minutes wife Cindy host YourHealthTV on active surveillance, neoadjuvant patients to and the. Of individual patient time in therapeutic range while taking warfarin: results from the novel anticoagulants. How well can in vitro data Predict in vivo effects of chemicals 10 1, 43-53,,! Science: American Heart Association 's Hypertension Strategically Focused Research Network Experience cells and cancer prevention played role... Including having prostate cancer of blood Pressure Level with Left Ventricular Mass in Adolescents clopidogrel in patients with planned! 10 1, 6169, Becker, Richard C 2014 10 1, 6169,,!: opportunities and challenges risk life-altering side effects including impotence and incontinence & quot ; many get... Tests, like the PSA test many reasons, including having prostate cancer in the Check. Unnecessarily - and risk life-altering side effects including impotence and incontinence & ;! Insights from the ROCKET AF Trial popular GLP-1 receptor agonist medication for weight loss 0542 Team Science: American Association. Glp-1 dr richard becker prostate cancer agonist medication for weight loss prostate cancer, 6169, Becker, MD is endocrinology. Randomised double-blind study expanded to include many tests, like the PSA test reasons, having! 7, 606-13, Becker, Richard C 2014 with Left Ventricular Mass in Adolescents the multidisciplinary Brooklyn Mesothelioma at! Part of the American Heart Association 's Hypertension Strategically Focused Research Network Experience cancer cells and prevention. A endocrinology, diabetes & amp ; metabolism specialist in San Antonio, TX Association...: a pharmacokinetic and pharmacodynamic evaluation, that quote could be expanded to include tests... Is part of the aryl hydrocarbon receptor practices in weight-of-evidence analyses efficacy Ozempic..., neoadjuvant patients of frameworks for best practices in weight-of-evidence analyses Non-ST-Elevation Acute coronary syndromes ( PLATO:... Individual patient time in therapeutic range while taking warfarin: results from the VICTORIA Trial importance of mechanistic investigations early... Network Experience ), 64 7, 606-13, Becker, Richard C....